Abstract

Interventional ERCP and EUS procedures are associated with known risks. These procedural risks may be greater in patients with hepatic cirrhosis due to decreased hepatic synthetic function. We sought to examine whether the severity of cirrhosis was associated with greater incidence of adverse events after EUS/ERCP.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call